// App-Quantinova.ai

: Long-term outcomes of antifibrotic treatments in patients with idiopathic pulmonary fibrosis: Real-world experience

Researchers

Presenter

  • Sibel Naycı

Principal Investigators

  • Demet Polat

  • Eylem Sercan Ozgur

  • Cengiz Özge

Medical Centers

  • Mersin University, Mersin, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Nintedanib

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved